Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Sep 13, 2020 1:37am
424 Views
Post# 31549379

QSC Mgmt. & their friends own lot more share compare to us

QSC Mgmt. & their friends own lot more share compare to us QuestCap Management will move QSC share price as management and their friends own lot more shares compare to us. They benefit more by hiring invertor relation and promoting QuestCap.
 
I think QSC stock should start moving upward shortly. 165 QuestCubes supposed to be delivered by October 15, 2020. By that time combined with flu season covid-19 testing should be at the peak. Once all these 165 QuestCubes are close to launch date or worse case are all are setup and testing people. QuestCap will move upward and no short trader or group can keep it at 0.20, 0.50 or a $1 because future revenue number are big. As everyone think fall and winter season suppose to be Hight demand and competition in covid-19 testing labs is not much.
 
Stocks are traded based on future revenue and progress. QuestCap can start announcing weekly testing numbers and even at half of those $270,000 per month per QuestCubes numbers this stock should be trading over $2. Here is why: Even at half of those number QuestCap should be generating 135,000 per QuestCap per month, so 135,000x165 comes to $22 million per month and $264 million per year now convert this to Canadian dollars  about $340 million and make 40% profit margin $136 million then stock usually trade about 5-15 time of the profit and with this QuestCap market cap even with 5 times should be $650 to $700 million and right now we are at $30 million market cap. Even with margin of error we should be trading over $2 within 2020. I am sure QuestCubes will be running close to capacity in the fall and winter season. So, more revenue in return larger market cap and close to capacity double the market cap. Tell me if anyone think my math is wrong?
 
All QuestCap needs to do is start adverting and promoting QuestCubes so, people should be waiting for QuestCubes launch. They need to spend some money starting now, not after they launch. QuestCap testing are much lower compare to competition cost wise. So, make people aware of that and take advantage of this. If they start promoting $59 covid-19 testing, guaranteed, they will get free advertising from the media.
 
I know QuestCap own only 28% of Columbian Sanaty IPS S.A full medical service but when you combine that Sanaty IPS S.A have their own Laboratory. Sanaty will focus on both wholesale institutional channels and the IPS retail laboratory channels to generate sales. So, when you combine both wholesale and retail, they can generate good revenue and any money generated by any sales add up quickly for QuestCap even if they are getting only 28% of the profit.
 
Once all these QuestCubes are launched and QuestCap start promoting QuestCubes. Once they start announcing projected revenue and maybe start posting people waiting in the lineup to get tested at QuestCubes. What you guys think going to happen. I think slowly big boy will take notice and start buying. I am sure they will be promoting QuestCap once they are close to launch date as they own more QuestCap shares compare to us little investors.
 
We are only counting on QuestCubes, once any of other investment announce any progress can be a bonus or in some cases even bigger reward then we think.
  1. Sunnybrook Research Institute,
  2. Spectral Analytics, Inc.
  3. Amino Therapeutics,
  4. Mount Sinai Hospital,
  5. Glenco Medical Corp,
 
Also, if QuestCap announce expanding covid-19 testing to any other country, selling more testing kits to partners directly or thru PCL/MTJR, adding more services through QuestCubes.
 
Everyone needs to do their own due diligence but for myself I think I have little to lose lot to gain by holding QSC shares at least for another 4-6 months.

<< Previous
Bullboard Posts
Next >>